Tag: MindImmune Therapeutics
Five Questions With: Isaac Stoner
Isaac Stoner is the newly appointed CEO of MindImmune Therapeutics, a University of Rhode Island spinout company working to develop novel treatments for Alzheimer’s...
MindImmune Therapeutics $30M funding round, 6th tenant set stage for Ocean...
PROVIDENCE – As the prevalence of Alzheimer’s disease grows, typical treatments for the neurodegenerative illness are rooted in an approach that’s about 90 years old.
And that treatment shows...
MindImmune Therapeutics raises $30M in Series A funding, appoints new CEO
PROVIDENCE – MindImmune Therapeutics, a company developing innovative treatments for Alzheimer's and other neurodegenerative diseases, announced this week that it has raised $30 million...
R.I.: Small state, big impact
It is easy to see why Glenn Robertelli is bullish on Rhode Island life sciences. In 2023, the sector employed more than 6,000 Rhode...
Ocean State Labs’ first 5 tenants unveiled
PROVIDENCE – The R.I. Life Science Hub on Wednesday announced the first five companies lined up to occupy space in Ocean State Labs, the...
MindImmune Therapeutics agrees to acquire two programs from H. Lundbeck
SOUTH KINGSTOWN –MindImmune Therapeutics Inc. has entered into agreements with H. Lundbeck A/S to acquire programs and will develop candidates from these programs as...
R.I. Commerce Corp. awards job creation incentives, Innovation Vouchers
PROVIDENCE — An Atlanta-based company, Epiq Systems Inc., will receive state job creation incentives for locating a new data analytics office in Rhode Island,...
Commerce RI to consider Qualified Jobs Incentive for Epiq Systems to...
PROVIDENCE – The R.I. Commerce Corp. board of directors is scheduled to meet Monday evening to discuss and consider tax incentives, Innovation Campus committee...
URI graduate students launch pharmaceutical company
SOUTH KINGSTOWN – Three doctoral students at the University of Rhode Island’s College of Pharmacy have started a company that harnesses big data in a...
- Featured Event -
